Adverse Event, Corona Virus Infection, COVID
Conditions
Brief summary
Testing use of predictive analytics to predict which COVID-19+ patients are at low risk for an adverse event (ICU transfer, intubation, mortality, hospice discharge, re-presentation to the ED, oxygen requirements exceeding nasal cannula at 6L/Min) in the next 96 hours
Detailed description
To assess if display of low risk of adverse event in EPIC can safely reduce length of stay and plan for discharge.
Interventions
OTHEREPIC risk score display
Display of risk score/ colored flag in Epic patient list column
Sponsors
NYU Langone Health
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
Adult hospitalized COVID19+ patients predicted to have no adverse event at 96 events with a threshold at 90% PPV, with at least one low risk during their admission who are discharged alive and have not been in the ICU
Exclusion criteria
Age \< 18 years not hospitalized for COVID19+.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduction in days from first low-risk score to discharge | 96 Hours | Reduction in days from first low-risk score to discharge |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Reduction in length of stay (LOS) | 96 hours | Reduction in LOS for green patients that have not been in the ICU |
| Reduction in GTD vs. LOS | 96 hours | Reduction in GTD vs. LOS for all green patients discharged alive vs all patients discharged alive |
| No change in 30 day re-ED presentation or hospital admission rate for cohort | 96 hours | No change in 30 day re-ED presentation or hospital admission rate for cohort |
Other
| Measure | Time frame |
|---|---|
| Re-presentation to ED | 96 hours |
| Readmission to hospital | 96 hours |
| Mortality | 96 hours |
| Postdischarge mortality | 96 hours |
Countries
United States
Outcome results
None listed